Skip to content

Effect of esketamine on postoperative cognitive dysfunction in elderly patients with gastrointestinal cancer

Effect of esketamine on postoperative cognitive dysfunction in elderly patients with gastrointestinal cancer

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077556
Enrollment
Unknown
Registered
2023-11-13
Start date
2023-11-13
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

Experimental group:Induction and maintenance with esketamine

Sponsors

Hebei General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Scheduled for gastrointestinal cancer surgery; (2)Age=60 years; (3) American Society of Anesthesiologists (ASA) physical status ?–III; (4)The patient and their family members agree and sign an informed consent form for anesthesia.

Exclusion criteria

Exclusion criteria: (1) Comorbid psychiatric disorders unable to cooperate; (2) Severe hepatic and renal dysfunction, severe visual and auditory impairment; (3) Severe hypertension, intracranial space occupation and intracranial hypertension; (4) Glaucoma and hyperthyroidism; and (5) Comorbid cognitive dysfunction disorders such as dementia.

Design outcomes

Primary

MeasureTime frame
Mini-mental State Examination, MMSE;

Secondary

MeasureTime frame
IL-6;Brain Derived Neurotrophic Factor;Pain score;

Countries

China

Contacts

Public ContactJianli Li

Hebei General Hospital

hblijianli@163.com+86 137 8511 8676

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026